News
These are South Florida's most expensive colleges © 2025 American City Business Journals. All rights reserved. Use of and/or ...
1don MSNOpinion
Reclaiming American leadership in healthcare innovation: The ‘Make American Health Tech Great Again’ call to action
A patient-centric ecosystem means your medical information follows you and every innovation starts with the question: How ...
5don MSN
CVS Caremark ordered to pay $290M after Medicare fraud scheme exposed by former Aetna whistleblower
Whistleblower Sarah Behnke's lawsuit leads to a $290 million judgment against CVS Caremark for overcharging Medicare on ...
(Reuters) -CVS Health, which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention ...
Chief Judge Mitchell Goldberg tripled to $285 million the damages he had ordered CVS Caremark to pay in June, citing the ...
CVS Health (NYSE:CVS), one of the leading health insurers in the U.S. and owner of the Pharmacy Benefit Manager Caremark, ...
11h
LGBTQ Nation on MSNCVS Health slammed for “shameful” refusal to cover revolutionary HIV drug
Advocates have claimed that CVS’s refusal to cover Yeztugo violates the Affordable Care Act (ACA), which requires insurers to ...
Primary care physicians and the state Senate’s health care point person are questioning a proposed partnership between Mass ...
The owner of the U.S.' largest pharmacy benefit manager is declining to cover Gilead Sciences’ long-acting HIV prevention ...
A Pennsylvania judge has ordered CVS to pay $289 million in damages as part of a long-running whistleblower case. | A ...
Those with private health insurance expected to have an easier time getting vaccines than those on Medi-Cal if CDC changes ...
Investing.com -- CVS Health (NYSE: CVS) will not include Gilead Sciences (NASDAQ: GILD )’ new HIV prevention drug Yeztugo in its commercial plans for the time being, despite the medication’s proven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results